ARTICLE | Company News
Cellular Biomedicine, GE in China cell manufacturing deal
April 11, 2017 8:38 PM UTC
Cellular Biomedicine Group Inc. (NASDAQ:CBMG) said it partnered with the GE Healthcare Life Science China unit of General Electric Co. (NYSE:GE) to jointly develop automated systems for manufacturing chimeric antigen receptor T cell and stem cell therapies. The partners said the system will be designed to minimize variability in cell production, improve throughput and reduce costs.
The partners will establish a joint laboratory in Shanghai to develop the system...